Injecting functional adenosine deaminase into a patient's (lacking $ADA$ gene) blood cells may be considered as

  • A
    Gene therapy
  • B
    Enzyme replacement therapy
  • C
    Both $(a)$ and $(b)$
  • D
    Genetic engineering

Explore More

Similar Questions

$\text{ELISA}$ is :-

At present,about ........ recombinant therapeutics have been approved for human use the world over. Out of these,........ are being marketed in India.

Who was the first patient who was given gene therapy? Why was the given treatment recurrent in nature?

Give scientific reasons: In earlier times,insulin was extracted from the pancreas of slaughtered cattle.

In the treatment of $ADA$ deficiency during gene therapy,which cells are collected from the patient's blood?

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo